The Journal

Weight-Loss Drugs Are Gobbling Up Small Town Budgets

As small towns add GLP-1 drugs to employee health plans, unexpected premium hikes are straining local budgets.

Small towns are experiencing significant financial strain due to unexpected increases in health insurance premiums driven by the growing use of GLP-1 weight-loss drugs.

12
19 minJun 29, 2026The Journal.

Prepared by GenPodAI-assisted and grounded in publisher-provided material

Listen to the original

Key takeaways

01

Rising Insurance Costs

Small towns that added GLP-1 weight-loss drugs to employee health insurance plans are facing huge, unexpected premiums.

12
02

Widespread Adoption

Many small towns across the country have incorporated these drugs into their benefits packages, leading to broader economic impacts.

1
03

Expert Analysis

The episode features insights from a Belchertown, MA selectwoman and WSJ’s Owen Tucker-Smith on the economics affecting towns nationwide.

3

Ask GenPod next

Keep the question moving.

01

“How do GLP-1 drugs impact municipal budgeting?”

02

“What strategies are towns using to manage rising health insurance costs?”

03

“How does the adoption of weight-loss drugs vary by region?”

Questions

Questions to carry into the episode.

Why are small towns seeing unexpected premium hikes?

The continued growth in the use of GLP-1 weight-loss drugs added to employee health insurance plans is driving up costs.

12
Who provides perspective on this economic trend?

Imani Moise speaks with a selectwoman from Belchertown, MA, and WSJ’s Owen Tucker-Smith.

3
What is the scope of this issue?

The financial impact is being felt by towns around the country as they navigate these new healthcare costs.

23

Experts

Voices named in the source.

Imani Moise

Host

3

Owen Tucker-Smith

WSJ Reporter

3

Sources and disclosure

Where this guide comes from.

Primary material

Weight-Loss Drugs Are Gobbling Up Small Town Budgets

The Journal. · Jun 29, 2026
How this guide was prepared

GenPod used an AI-assisted workflow to organize publisher-provided show notes into a listening guide. It is not independent reporting or fact-checking; verify important claims against the source episode.

Read our methodologyReport a correction
Source note

This episode is part of The Journal, featuring reporting from The Wall Street Journal.

  1. Publisher show notes · Excerpt 1

    Many small towns across the country added GLP-1 weight-loss drugs to their employee health insurance plans.

  2. Publisher show notes · Excerpt 2

    Now, some of those towns are being hit with huge unexpected premiums as use of the drugs continues to grow.

  3. Publisher show notes · Excerpt 3

    Imani Moise speaks to a selectwoman from Belchertown, MA who helped navigate her town through a devastating bill and WSJ’s Owen Tucker-Smith takes us through the economics for towns around the country.

  4. Publisher show notes · Excerpt 4

    Further Listening:

  5. Publisher show notes · Excerpt 5

    - Trillion Dollar Shot

  6. Publisher show notes · Excerpt 6

    - Novo Nordisk's CEO Has a Comeback Plan

  7. Publisher show notes · Excerpt 7

    - Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

  8. Publisher show notes · Excerpt 8

    Sign up for WSJ’s free What’s News newsletter.

  9. Publisher show notes · Excerpt 9

    Learn more about your ad choices. Visit megaphone.fm/adchoices

Related listening guides

Choose what to hear next.